Zhangyi He

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ Bayesian <scp>MCPMod</scp> 2022 Frank Fleischer
Sebastian Bossert
Qiqi Deng
Christina Loley
Jana Gierse
3
+ PDF Chat Combining Multiple Comparisons and Modeling Techniques in Dose‐Response Studies 2005 Frank Bretz
José Pinheiro
Michael Branson
3
+ PDF Chat Power prior distributions for regression models 2000 Ming‐Hui Chen
Joseph G. Ibrahim
2
+ Bayesian Approaches to Clinical Trials and Health‐Care Evaluation 2003 David J. Spiegelhalter
Keith R. Abrams
Jonathan P. Myles
2
+ PDF Chat Model‐based dose finding under model uncertainty using general parametric models 2013 José Cirı́aco Pinheiro
Björn Bornkamp
Ekkehard Glimm
Frank Bretz
2
+ PDF Chat On weakly informative prior distributions for the heterogeneity parameter in Bayesian random‐effects meta‐analysis 2021 Christian Röver
Ralf Bender
Sofia Dias
Christopher H. Schmid
Heinz Schmidli
Sibylle Sturtz
Sebastian Weber
Tim Friede
2
+ Robust meta‐analytic‐predictive priors in clinical trials with historical control information 2014 Heinz Schmidli
Sandro Gsteiger
Satrajit Roychoudhury
Anthony O’Hagan
David J. Spiegelhalter
Beat Neuenschwander
2
+ Bayesian clinical trials 2006 Donald A. Berry
2
+ Summarizing historical information on controls in clinical trials 2010 Beat Neuenschwander
Gorana Capkun-Niggli
Michael Branson
David J. Spiegelhalter
2
+ PDF Chat Bayesian bivariate meta-analysis of correlated effects: Impact of the prior distributions on the between-study correlation, borrowing of strength, and joint inferences 2016 Danielle L. Burke
Sylwia Bujkiewicz
Richard D. Riley
1
+ Efficiencies of platform clinical trials: A vision of the future 2016 Benjamin R. Saville
Scott Berry
1
+ PDF Chat A Bayesian basket trial design using a calibrated Bayesian hierarchical model 2018 Yiyi Chu
Ying Yuan
1
+ PDF Chat Comparison of different approaches for dose response analysis 2018 Saswati Saha
Werner Brannath
1
+ Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation 2019 Tom Greene
Jian Ying
Edward F. Vonesh
Hocine Tighiouart
Andrew S. Levey
Josef Coresh
Jennifer S. Herrick
Enyu Imai
Tazeen H. Jafar
Bart Maes
1
+ Comparison of methods for control allocation in multiple arm studies using response adaptive randomization 2019 Kert Viele
Kristine Broglio
Anna McGlothlin
Benjamin R. Saville
1
+ Adaptive platform trials: definition, design, conduct and reporting considerations 2019 1
+ Statistical considerations on implementing the MCP-Mod method for binary endpoints in clinical trials 2020 Jingjing Chen
Tina Liu
1
+ Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper) 2006 Andrew Gelman
1
+ Adaptive Designs for Clinical Trials in Nephrology 2024 Rathika Krishnasamy
Meg Jardine
1
+ Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012 2014 Leonard Sacks
Hala Shamsuddin
Yuliya Yasinskaya
Khaled Bouri
Michael Lanthier
Rachel E. Sherman
1
+ Adaptive modelling of dose–response relationships using smoothing splines 2009 Simon Kirby
Peter Colman
Mark Morris
1
+ PDF Chat Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models 2012 Brian P. Hobbs
Daniel J. Sargent
Bradley P. Carlin
1
+ The Platform Trial 2015 Scott Berry
Jason T. Connor
Roger Lewis
1
+ Nonparametric Regression and Generalized Linear Models 1993 P.J. Green
Bernard W. Silverman
1
+ Borrowing Information across Subgroups in Phase II Trials: Is It Useful? 2013 Boris Freidlin
Edward L. Korn
1
+ On the Half-Cauchy Prior for a Global Scale Parameter 2012 Nicholas G. Polson
James G. Scott
1
+ Dose Finding in Drug Development 2006 Naitee Ting
1